Aim To report in a uniform way the change in MHT use in European countries. To evaluate whether the variability of the MHT changes were related to some medical indicators. Materials and methods IMS Health provided MHT sales data for the years 2002 till 2010 for 17 countries. We tested several hypotheses to explain the heterogeneity of MHT use changes.SCOPUS: ar.jinfo:eu-repo/semantics/publishe
Samples of about 300 women aged 40-69 were interviewed in Denmark and the Netherlands about consulta...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...
Aim To report in a uniform way the change in MHT use in European countries. To evaluate whether the ...
International audienceObjectives Menopausal hormone therapy (MHT) use is characterized by important ...
Introduction The use of menopausal hormone therapy (MHT) has decreased in many countries in the past...
BACKGROUND: Prescribing of menopausal hormone therapy (MHT) declined drastically after publication o...
Background: To examine the differences in menopausal hormone therapy (MHT) use and user profiles amo...
Objective: To determine regional variations in the prevalence and applied therapy regimes of current...
Objectives: To describe the trends in the prevalence of use menopausal hormone therapy (MHT) in Swed...
<p><b>Copyright information:</b></p><p>Taken from "Differences in Menopausal Hormone Therapy Use amo...
Background Menopausal hormone therapy (MHT) is used to treat menopausal symptoms. The use of MHT dec...
Objective: Did the publication of the Women Health Initiative (WHI) trial in 2002 and the Million Wo...
Objective: Did the publication of the Women Health Initiative (WHI) trial in 2002 and the Million Wo...
International audienceThe current evaluation of the benefit/risk ratio associated with menopausal ho...
Samples of about 300 women aged 40-69 were interviewed in Denmark and the Netherlands about consulta...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...
Aim To report in a uniform way the change in MHT use in European countries. To evaluate whether the ...
International audienceObjectives Menopausal hormone therapy (MHT) use is characterized by important ...
Introduction The use of menopausal hormone therapy (MHT) has decreased in many countries in the past...
BACKGROUND: Prescribing of menopausal hormone therapy (MHT) declined drastically after publication o...
Background: To examine the differences in menopausal hormone therapy (MHT) use and user profiles amo...
Objective: To determine regional variations in the prevalence and applied therapy regimes of current...
Objectives: To describe the trends in the prevalence of use menopausal hormone therapy (MHT) in Swed...
<p><b>Copyright information:</b></p><p>Taken from "Differences in Menopausal Hormone Therapy Use amo...
Background Menopausal hormone therapy (MHT) is used to treat menopausal symptoms. The use of MHT dec...
Objective: Did the publication of the Women Health Initiative (WHI) trial in 2002 and the Million Wo...
Objective: Did the publication of the Women Health Initiative (WHI) trial in 2002 and the Million Wo...
International audienceThe current evaluation of the benefit/risk ratio associated with menopausal ho...
Samples of about 300 women aged 40-69 were interviewed in Denmark and the Netherlands about consulta...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...
Aims To estimate the diffusion of new safety information concerning postmenopausal hormonal replacem...